173 related articles for article (PubMed ID: 30640686)
41. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
42. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
44. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
[TBL] [Abstract][Full Text] [Related]
45. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
[TBL] [Abstract][Full Text] [Related]
46. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
[TBL] [Abstract][Full Text] [Related]
47. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
[TBL] [Abstract][Full Text] [Related]
48. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis.
Papathemelis T; Hassas D; Gerken M; Klinkhammer-Schalke M; Scharl A; Lux MP; Beckmann MW; Scharl S
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2019-2027. PubMed ID: 30039227
[TBL] [Abstract][Full Text] [Related]
49. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
50. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
Wen HW; Zhang LD
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
[TBL] [Abstract][Full Text] [Related]
51. Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer.
Nasioudis D; Heyward QD; Haggerty AF; Giuntoli Ii RL; Burger RA; Morgan MA; Ko EM; Latif NA
Surg Oncol; 2020 Sep; 34():7-12. PubMed ID: 32103792
[TBL] [Abstract][Full Text] [Related]
52. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.
Ørtoft G; Lausten-Thomsen L; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2019 Sep; 30(5):e84. PubMed ID: 31328462
[TBL] [Abstract][Full Text] [Related]
53. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer.
Papadia A; Imboden S; Siegenthaler F; Gasparri ML; Mohr S; Lanz S; Mueller MD
Ann Surg Oncol; 2016 Jul; 23(7):2206-11. PubMed ID: 26790667
[TBL] [Abstract][Full Text] [Related]
54. Treatment failure in endometrial carcinoma.
Huang HJ; Tang YH; Chou HH; Yang LY; Chao A; Huang YT; Lin G; Liu FY; Chang TC; Lai CH
Int J Gynecol Cancer; 2014 Jun; 24(5):885-93. PubMed ID: 24819657
[TBL] [Abstract][Full Text] [Related]
55. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
56. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
[TBL] [Abstract][Full Text] [Related]
57. Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients.
Ye S; You Y; Yang J; Cao D; Bai H; Huang H; Wu M; Chen J; Lang J; Shen K
Int J Gynecol Cancer; 2014 Nov; 24(9):1590-6. PubMed ID: 25254564
[TBL] [Abstract][Full Text] [Related]
58. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
59. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer?
Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M
Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819
[TBL] [Abstract][Full Text] [Related]
60. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
